BridgeBio Pharma, Inc. ($BBIO)
Kumar Neil โ Director
Shares
30,970
Price
$75.25
Total Value
$2,330,492.50
Nearby Earnings
Feb 19, 2026
EPS:Est: -0.74
Revenue:Est: $149.07M
Feb 24, 2026
EPS:Est: -0.75
Revenue:Est: $149.07M
Transaction Details
| Insider | Kumar Neil |
|---|---|
| Title | Director |
| Transaction Date | Feb 16, 2026 |
| Transaction Code | F Tax Withholding |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 16, 2026 |
| Shares Purchased | 30,970 |
| Price per Share | $75.25 |
| Total Value | $2,330,492.50 |
| Shares Owned After | 262,504 |
| Derivative | No |
| Accession Number | 0001470831-26-000188 |
| Document | View SEC Filing |